Catalent Expert Presenting at FDA/Xavier University Global Outsourcing Conference
Somerset, NJ, June 10, 2010 — Sharon M. Johnson, Senior Vice President of Quality & Regulatory Affairs for Catalent Pharma Solutions will be presenting on "Compliance Strategy of a Global Contract Organization --- Managing Global Regulatory Requirements and Client Expectations," at the First Annual FDA/Xavier University Global Outsourcing Conference, June 13-16, 2010 on the campus of Xavier University in Cincinnati, Ohio.
Ms. Johnson will provide the perspective of a large global organization. The objective of the presentation is to educate conference attendees on how to remain compliant with global regulatory requirements, while managing multiple client expectations.
Ms. Johnson is a Quality professional with more than 25 years of experience in the pharmaceutical industry, predominantly in the area of sterile products and biosciences.
She joined Catalent after six years at GE Healthcare where she was Vice President of Quality for GE Healthcare, Medical Diagnostics in Buckinghamshire, England. Ms. Johnson holds a Post Graduate Diploma in Industrial Pharmaceutical Studies with Distinction from Brighton University and holds a B.S. Honours Degree in Biological Sciences/Microbiology from North East Surrey College of Technology.
Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 people at 30 facilities worldwide and in fiscal 2009 generated more than $1.6 billion in annual revenue. For more information, visit www.catalent.com .